Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
GJA4	2701	broad.mit.edu	37	1	35260771	35260771	+	Silent	SNP	C	C	G			THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	g.chr1:35260771C>G	ENST00000342280.4	+	2	1045	c.957C>G	c.(955-957)ccC>ccG	p.P319P		NM_002060.2	NP_002051.2	P35212	CXA4_HUMAN	gap junction protein, alpha 4, 37kDa	319		NA	P -> S (in allele CX37*2; dbSNP:rs1764391).	NA	cell-cell junction assembly	integral to plasma membrane				NS(1)|central_nervous_system(1)|endometrium(1)|large_intestine(3)|lung(3)|prostate(4)|stomach(1)	14		Myeloproliferative disorder(586;0.0255)|all_neural(195;0.234)				GCCAAAAACCCCCAAGTCGTC	0.587		NA				NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						43	41	42	NA		NA	NA	1		NA		NA									NA				35260771		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000187513	HGNC:4278	NM_002060	Approved	uc001bya.3	NA	A8K698|D3DPR4|Q9P106|Q9UBL1|Q9UNA9|Q9UNB0|Q9UNB1|Q9Y5N7	ENST00000342280.4	37	CCDS30669.1																																																																																			GJA4-001	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000011556.1	31.539277	KEEP		+	36.780338	0.203125	13	51	---	---	---	---	1	1	56	168	0	99	17	69	0	99	2	0	0	0	0	0	0	17	69	0	99	2	TP
MAATS1	89876	broad.mit.edu	37	3	119462867	119462867	+	Silent	SNP	C	C	T			THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	g.chr3:119462867C>T	ENST00000273390.5	+	14	1803	c.1726C>T	c.(1726-1728)Cta>Tta	p.L576L	RP11-169N13.4_ENST00000489428.2_RNA	NM_033364.3	NP_203528.2			MYCBP-associated, testis expressed 1	NA		NA		NA							NA						AGGAAGGGCACTAGCAGACAT	0.488		NA				NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						94	81	86	NA		NA	NA	3		NA		NA									NA				119462867		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000183833	HGNC:24010	NM_033364	Approved		NA		ENST00000273390.5	37	CCDS2994.1																																																																																			MAATS1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000355222.1	170.040532	KEEP		+	170.109404	0.473684	54	60	---	---	---	---	1	1	28	15	0	96	68	81	0	96	2	0	0	0	0	0	0	68	81	0	96	2	TP
BDH1	622	broad.mit.edu	37	3	197238954	197238954	+	Missense_Mutation	SNP	C	C	T	rs145598252		THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	g.chr3:197238954C>T	ENST00000392379.1	-	8	1245	c.844G>A	c.(844-846)Gcc>Acc	p.A282T	BDH1_ENST00000358186.2_Missense_Mutation_p.A282T|BDH1_ENST00000441275.1_Missense_Mutation_p.A195T|BDH1_ENST00000392378.2_Missense_Mutation_p.A282T	NM_203314.2	NP_976059.1	Q02338	BDH_HUMAN	3-hydroxybutyrate dehydrogenase, type 1	282		NA		NA	cellular lipid metabolic process|ketone body biosynthetic process|ketone body catabolic process	mitochondrial matrix	3-hydroxybutyrate dehydrogenase activity			endometrium(2)|large_intestine(1)|lung(6)|ovary(1)|skin(1)	11	all_cancers(143;3.35e-10)|Ovarian(172;0.0418)|Breast(254;0.0437)	Lung NSC(153;0.118)	Epithelial(36;3.52e-24)|all cancers(36;1.79e-22)|OV - Ovarian serous cystadenocarcinoma(49;2.32e-19)|LUSC - Lung squamous cell carcinoma(58;1.02e-06)|Lung(62;1.34e-06)	GBM - Glioblastoma multiforme(93;0.0977)	NADH(DB00157)	TCCATCTTGGCGATCTTTTCA	0.582		NA				NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA	C	THR/ALA,THR/ALA,THR/ALA	1,4405	2.1+/-5.4	0,1,2202	187	157	167	NA	844,844,844	2.9	0.2	3	dbSNP_134	167	0,8600	NA	0,0,4300	no	missense,missense,missense	BDH1	NM_004051.4,NM_203314.2,NM_203315.2	58,58,58	0,1,6502	TT,TC,CC	NA	0.0,0.0227,0.0077	benign,benign,benign	282/344,282/344,282/344	197238954	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000161267	HGNC:1027	NM_004051	Approved	uc003fxs.3	NA	D3DXC0|Q96ET1|Q9BRZ4	ENST00000392379.1	37	CCDS3328.1	.	.	.	.	.	.	.	.	.	.	C	12.59	1.983110	0.34942	2.27E-4	0.0	ENSG00000161267	ENST00000392378;ENST00000358186;ENST00000392379;ENST00000441275	D;D;D;D	0.93366	-3.21;-3.21;-3.21;-3.21	5.85	2.87	0.33458	NAD(P)-binding domain (1);	0.257583	0.43919	D	0.000507	D	0.87799	0.6268	L	0.42744	1.35	0.42674	D	0.993522	B	0.25809	0.135	B	0.17098	0.017	T	0.81486	-0.0911	10	0.17369	T	0.5	.	10.7729	0.46334	0.2568:0.6185:0.1247:0.0	.	282	Q02338	BDH_HUMAN	T	282;282;282;195	ENSP00000376183:A282T;ENSP00000350914:A282T;ENSP00000376184:A282T;ENSP00000411014:A195T	ENSP00000350914:A282T	A	-	1	0	BDH1	198723351	1.000000	0.71417	0.163000	0.22734	0.690000	0.40134	1.575000	0.36493	0.890000	0.36211	0.655000	0.94253	GCC	BDH1-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		215.013719	KEEP		-	216.597558	0.398876	71	107	---	---	---	---	1	1	35	35	0	173	85	125	0	173	2	0	0	0	0	0	0	85	125	0	173	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).	NA	activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""	NA	Cardio-facio-cutaneous syndrome	NA	Cardiofaciocutaneous syndrome	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Colon(40;35 892 2973 5743 27438)	NA	Dom	yes	NA	7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA						112	104	107	NA		NA	NA	7		NA		NA									NA				140453136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	80.732675	KEEP		-	81.749104	0.371429	26	44	---	---	---	---	1	0.9998504	13	16	0	76	35	61	0	76	2	1	1	548	950	1	1084	35	61	0	76	7	TP
MYO5C	55930	broad.mit.edu	37	15	52529700	52529700	+	Missense_Mutation	SNP	T	T	A			THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	g.chr15:52529700T>A	ENST00000261839.7	-	22	3008	c.2847A>T	c.(2845-2847)agA>agT	p.R949S	MYO5C_ENST00000443683.2_3'UTR	NM_018728.3	NP_061198.2	Q9NQX4	MYO5C_HUMAN	myosin VC	949		NA		NA		myosin complex	actin binding|ATP binding|calmodulin binding|motor activity			breast(1)|central_nervous_system(3)|cervix(1)|endometrium(8)|kidney(7)|large_intestine(15)|lung(12)|ovary(7)|prostate(3)|skin(6)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	66				all cancers(107;0.0137)		CATCCCTGTATCTCTTCCCCT	0.512		NA				NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						313	321	318	NA		NA	NA	15		NA		NA									NA				52529700		2045	4209	6254	SO:0001583	missense				HGNC:7604	NM_018728	Approved	uc010bff.3	NA		ENST00000261839.7	37	CCDS42036.1	.	.	.	.	.	.	.	.	.	.	T	8.735	0.917686	0.17982	.	.	ENSG00000128833	ENST00000261839	T	0.17528	2.27	5.56	3.18	0.36537	.	0.371038	0.30011	N	0.010624	T	0.09335	0.0230	N	0.24115	0.695	0.09310	N	0.999997	B	0.02656	0.0	B	0.06405	0.002	T	0.36720	-0.9736	10	0.09338	T	0.73	.	8.6657	0.34118	0.0:0.2841:0.0:0.7159	.	949	Q9NQX4	MYO5C_HUMAN	S	949	ENSP00000261839:R949S	ENSP00000261839:R949S	R	-	3	2	MYO5C	50316992	1.000000	0.71417	0.598000	0.28837	0.034000	0.12701	1.464000	0.35288	0.924000	0.37069	0.533000	0.62120	AGA	MYO5C-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000419562.1	-122.75912	KEEP		-	7.279373	0.010593	5	467	---	---	---	---	1	0.4293024	2	133	0	554	6	628	0	554	2	0	0	0	0	0	0	6	628	0	554	2	TP
ULK3	25989	broad.mit.edu	37	15	75134762	75134762	+	Splice_Site	SNP	C	C	G			THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	g.chr15:75134762C>G	ENST00000440863.2	-	2	194		c.e2-1		ULK3_ENST00000569437.1_Splice_Site|ULK3_ENST00000568667.1_Splice_Site	NM_001099436.1	NP_001092906.1	Q6PHR2	ULK3_HUMAN	unc-51 like kinase 3	NA		NA		NA		cytoplasm	ATP binding|protein serine/threonine kinase activity			breast(2)	2						GAGTGTCCTTCTGCGAGACAG	0.557		NA				NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						187	184	185	NA		NA	NA	15		NA		NA									NA				75134762		1967	4153	6120	SO:0001630	splice_region_variant				HGNC:19703	NM_015518	Approved	uc010bkf.1	NA	B2RXK3|B4DRQ7|D3DW68|Q9NPN5|Q9UFS4	ENST00000440863.2	37	CCDS45305.1	.	.	.	.	.	.	.	.	.	.	C	17.22	3.333494	0.60853	.	.	ENSG00000140474	ENST00000440863;ENST00000418051	.	.	.	5.08	5.08	0.68730	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	17.0888	0.86617	0.0:1.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	-	.	.	ULK3	72921815	1.000000	0.71417	0.994000	0.49952	0.611000	0.37282	7.270000	0.78493	2.378000	0.81104	0.655000	0.94253	.	ULK3-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000421734.4	204.275498	KEEP	Intron	-	214.512264	0.27897	65	168	---	---	---	---	1	0.9999913	2	42	0	304	87	221	0	304	2	0	0	0	0	0	0	87	221	0	304	2	TP
BCAM	4059	broad.mit.edu	37	19	45317503	45317503	+	Silent	SNP	G	G	A			THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-J8-A3NZ-Tumor-SM-2SK2F	THCA-TCGA-J8-A3NZ-Normal-SM-2SK2I	g.chr19:45317503G>A	ENST00000391955.1	+	7	923	c.879G>A	c.(877-879)ggG>ggA	p.G293G	BCAM_ENST00000270233.6_Silent_p.G293G			P50895	BCAM_HUMAN	basal cell adhesion molecule (Lutheran blood group)	293	Ig-like C2-type 1.	NA		NA	cell-matrix adhesion	integral to plasma membrane	laminin binding|laminin receptor activity			central_nervous_system(1)|kidney(3)|large_intestine(4)|lung(9)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)	22	Lung NSC(12;0.000789)|all_lung(12;0.00218)	Ovarian(192;0.0728)|all_neural(266;0.112)				TCTGCCGGGGGGACGGCAGCC	0.672		NA				NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						48	48	48	NA		NA	NA	19		NA		NA									NA				45317503		2203	4299	6502	SO:0001819	synonymous_variant				HGNC:6722	NM_005581	Approved	uc002ozu.4	NA	A8MYF9|A9YWT5|A9YWT6|Q86VC7	ENST00000391955.1	37	CCDS42575.1																																																																																			BCAM-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		261.012345	KEEP		+	261.013612	0.50303	83	82	---	---	---	---	1	1	266	326	0	240	92	98	0	240	2	0	0	0	0	0	0	92	98	0	240	2	TP
